Figure 2. Percent of Adverse Events after 30 Days for Women Treated for Pelvic Inflammatory Disease by Treatment Group

You Are Here: AHRQ Home > Research Findings > Research in Action > Prescription Drug Therapies

Figure 2. Percent of Adverse Events after 30 Days for Women Treated for Pelvic Inflammatory Disease by Treatment Group

0.7% of inpatients and 0.9% of outpatients had a tubo-ovarian abscess; 1.5% of inpatients and 1.7% of outpatients had an adverse drug reaction; 3.4% of inpatients and 0.0% of outpatients had phlebitis; 18.4% of inpatients and 20.6% of outpatients had tenderness.

Source: Ness RB, Soper DE, Holley RL, et al. Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) randomized trial. Am J Obstet Gynecol 2002; 186(5):929-37.

Return to Document